ONPH Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Oncology Pharma Inc

Watchlist Manager

Watchlist

Price: 0.05 USD -27.01% Market Closed

Market Cap: $1.2m

	Oncology Pharma Inc OTC:ONPH	US
E	EFG International AG XBER:E2S	CH
H	Haemato AG F:HAEK	DE
	PolyPlank AB (publ) F:PP7	SE
	Data Call Technologies Inc OTC:DCLT	US
	One More Level SA F:1OJ	PL
	Burgerfi International Inc NASDAQ:BFI	US
	Global Compliance Applications Corp F:TK6	CA
	Triad Pro Innovators Inc OTC:TPII	US
M	MIX 1 Life Inc OTC:MIXX	US
K	Kairous Acquisition Corp Ltd NASDAQ:KACL	MY
	Centratama Telekomunikasi Indonesia Tbk PT IDX:CENT	ID
G	Guangdong Land Holdings Ltd F:GUW	HK
V	Vienna Insurance Group Wiener Versicherung Gruppe AG PSE:VIG	AT
	BitRush Corp F:0XSN	CA

Profitability Summary

Oncology Pharma Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

64%

Declining Gross Margin

64% > 64%

Negative Operating Margin

-75 315%

Declining Operating Margin

Exceptional Free Cash Flow Margin

12%

Declining Free Cash Flow Margin

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.